Medical Journal of The Islamic Republic of Iran (MJIRI)
Iran University of Medical Sciences
Thu, Nov 21, 2024
[Archive]
Volume 34, Issue 1 (2-2020)
Med J Islam Repub Iran 2020 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aghaei Zarch S M, Dehghan Tezerjani M, Talebi M, Vahidi Mehrjardi M Y. Molecular biomarkers in diabetes mellitus (DM). Med J Islam Repub Iran 2020; 34 (1) :196-203
URL: http://mjiri.iums.ac.ir/article-1-5591-en.html
URL: http://mjiri.iums.ac.ir/article-1-5591-en.html
Seyed Mohsen Aghaei Zarch 
, Masoud Dehghan Tezerjani , Mehrdad Talebi , Mohammad Yahya Vahidi Mehrjardi
, Masoud Dehghan Tezerjani , Mehrdad Talebi , Mohammad Yahya Vahidi Mehrjardi
Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , mosenaghaei123@gmail.com
Abstract: (2374 Views)
Background: Diabetes mellitus (DM) is a growing epidemic metabolic syndrome, which affects near 5.6% of the world’s population. Almost 12% of health expenditure is dedicated to this disorder. Discovering and developing biomarkers as a practical guideline with high specificity and sensitivity for the diagnosis, prognosis, and clinical management of DM is one of the subjects of great interest among DM researchers due to the long-lasting asymptomatic clinical manifestation of DM. In this study, we described a recently identified molecular biomarker involved in DM.
Methods: This review study was done at the Diabetes Research Center affiliated to Shahid Sadoughi University of Medical Sciences. PubMed, Scopus, Google Scholar, and Web of Science were searched using the following keywords: “diabetes mellitus”, “biomarker”, “microRNA”, “diagnostic tool” and “clinical manifestation.”
Results: A total of 107 studies were finally included in this review. After evaluating numerous articles, including original, meta-analysis, and review studies, we focused on molecular biomarkers involved in DM diagnosis and management.
Conclusion: Increasing interest in biomarkers associated with DM goes back to its role in decreasing diabetes-related morbidity and mortality. This review focused on major molecular biomarkers such as proteomic and microRNA (miRNAs) as novel and interesting DM biomarkers that can help achieve timely diagnosis of DM.
Methods: This review study was done at the Diabetes Research Center affiliated to Shahid Sadoughi University of Medical Sciences. PubMed, Scopus, Google Scholar, and Web of Science were searched using the following keywords: “diabetes mellitus”, “biomarker”, “microRNA”, “diagnostic tool” and “clinical manifestation.”
Results: A total of 107 studies were finally included in this review. After evaluating numerous articles, including original, meta-analysis, and review studies, we focused on molecular biomarkers involved in DM diagnosis and management.
Conclusion: Increasing interest in biomarkers associated with DM goes back to its role in decreasing diabetes-related morbidity and mortality. This review focused on major molecular biomarkers such as proteomic and microRNA (miRNAs) as novel and interesting DM biomarkers that can help achieve timely diagnosis of DM.
Type of Study: Review Article |
Subject:
Medical Genetics
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
